Haleon Reports 2.2% Organic Revenue Growth in Q1 2026 Amid Weak Cold and Flu Season

Haleon (NYSE:HLN) reported 2.2% organic revenue growth in Q1 2026, driven by its oral health segment and VMS category, despite a weak cold and flu season and declining consumer confidence. The company reiterated its full-year outlook and highlighted margin improvements and growth initiatives. Oral health led the portfolio with 8.3% organic revenue growth.

By MarketBeat Wed, April 29, 2026 at 1:46 PM GMT+3 6 min read · Yahoo Finance · April 29, 2026, 10:46 UTC

Tickers: $DHI $HLN $NVR $PHM

Topics: Cold and Flu Season Consumer Confidence Earnings Oral Health Product Innovation Revenue Growth VMS Growth

Read the full article at Yahoo Finance

More World news

Allstate Announces Quarterly Dividend of $1.08 Per Share Seeking Alpha · November 12, 2026, 18:01 UTC
Pinnacle Bankshares Increases Quarterly Dividend to $0.35 Per Share Seeking Alpha · November 12, 2026, 18:02 UTC
Avidbank Reports Third Quarter 2026 Earnings Growth Driven by Core Deposits and C&I Lending Motley Fool · November 12, 2026, 18:00 UTC
Equinor Raises Production Guidance and Establishes Share Buyback Framework Motley Fool · November 12, 2026, 18:00 UTC
Flex Announces Strategic Spin-off of Cloud and Power Infrastructure Segment into Axiom Motley Fool · November 12, 2026, 18:00 UTC
Extreme Networks Raises Fiscal 2027 Revenue Guidance Amid Strong SaaS Growth and Large Enterprise Bookings Motley Fool · November 12, 2026, 18:00 UTC
Federal Reserve to Designate October 2027 Meeting as Nonvoting Strategic Session CNBC · November 12, 2026, 17:48 UTC
Pelagos Insurance Capital Reports Mixed Q3 2026 Results with Revenue Beat and EPS Miss Seeking Alpha · November 12, 2026, 18:01 UTC
Aline Accounting Partners Secures $206 Million in Financing Led by Square Nine Capital PR Newswire · November 12, 2026, 18:00 UTC
Egan-Jones November 2026 Report Shows Soft CLO Issuance Amid Improving Credit Metrics PR Newswire · November 12, 2026, 18:00 UTC